VYOME HOLDINGS, INC. Liabilities, Noncurrent
VYOME HOLDINGS, INC. (HIND) had Liabilities, Noncurrent of $8.15 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-03-18
- 2025-09-30: Liabilities, Noncurrent $8.15K.
- 2025-06-30: Liabilities, Noncurrent $16.73K.
- 2024-12-31: Liabilities, Noncurrent $32.83K.
- 2020-09-30: Liabilities, Noncurrent $990.00K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2025-09-30 | $8.15K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $16.73K 8-K · filed 2025-09-02 |
| 2024-12-31 | $32.83K 10-K · filed 2026-03-18 |
| 2020-09-30 | $990.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.10M 10-Q · filed 2020-07-30 |
| 2019-12-31 | $567.00K 10-Q · filed 2020-11-06 |
| 2019-09-30 | $687.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $722.00K 10-Q · filed 2019-07-24 |
| 2019-03-31 | $819.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $48.00K 10-Q · filed 2019-11-08 |
| 2018-09-30 | $9.45M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $6.02M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $6.97M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $7.98M 10-K · filed 2019-02-22 |
| 2017-09-30 | $8.98M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $9.94M 10-Q · filed 2017-08-02 |
| 2016-12-31 | $9.88M 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |